Summit Therapeutics Inc vs Toyota Motor Corp — how do they compare? Summit Therapeutics Inc trades at $14.58 (market cap $10.48B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 20.3× Summit Therapeutics Inc's market cap, and Toyota Motor Corp pays a 3.51% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | TM | |
|---|---|---|
Market Cap | $10.48B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.32 | $248.29 |
52-Week Low | $13.05 | $166.50 |
Enterprise Value | $9.90B | $376.42B |
Dividend Yield | — | 3.51% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →